Interestingly, the phosphorylation of S6 and 4EBP1 in B cells, which are classic downstream molecules of the AKT/mTOR signaling pathway (22), showed no difference between HCs and D-LC patients (Figures 6C, D). This evidence concerns the gene MTOR and laryngotracheoesophageal cleft.